BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harding CM, Feldman MF. Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli. Glycobiology 2019;29:519-29. [PMID: 30989179 DOI: 10.1093/glycob/cwz031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 de Pinho Favaro MT, Atienza-Garriga J, Martínez-Torró C, Parladé E, Vázquez E, Corchero JL, Ferrer-Miralles N, Villaverde A. Recombinant vaccines in 2022: a perspective from the cell factory. Microb Cell Fact 2022;21:203. [PMID: 36199085 DOI: 10.1186/s12934-022-01929-8] [Reference Citation Analysis]
2 Szymanski CM. Bacterial glycosylation, it’s complicated. Front Mol Biosci 2022;9:1015771. [DOI: 10.3389/fmolb.2022.1015771] [Reference Citation Analysis]
3 Zhang Z, Nong F, Wang Y, Yan C, Gu Y, Song P, Sun X. Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity. Microb Cell Fact 2022;21. [DOI: 10.1186/s12934-022-01917-y] [Reference Citation Analysis]
4 Romano MR, Berti F, Rappuoli R. Classical- and bioconjugate vaccines: comparison of the structural properties and immunological response. Curr Opin Immunol 2022;78:102235. [PMID: 35988326 DOI: 10.1016/j.coi.2022.102235] [Reference Citation Analysis]
5 Tan YC, Lahiri C. Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years. Front Immunol 2022;13:900509. [PMID: 35720310 DOI: 10.3389/fimmu.2022.900509] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Kint N, Dubois T, Viollier PH. Genetic glyco-profiling and rewiring of insulated flagellin glycosylation pathways.. [DOI: 10.1101/2022.03.25.485807] [Reference Citation Analysis]
7 Alvarado-Obando M, Contreras N, León D, Botero L, Beltran L, Díaz D, Rodríguez-López A, Reyes LH, Alméciga-Díaz CJ, Sánchez OF. Engineering a heterologously expressed fructosyltransferase from Aspergillus oryzae N74 in Komagataella phaffii (Pichia pastoris) for kestose production. N Biotechnol 2022:S1871-6784(22)00015-2. [PMID: 35217201 DOI: 10.1016/j.nbt.2022.02.005] [Reference Citation Analysis]
8 Nothaft H, Szymanski CM. Bacterial Glycoprotein Biosynthesis. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00021-3] [Reference Citation Analysis]
9 Anish C, Beurret M, Poolman J. Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines. NPJ Vaccines 2021;6:150. [PMID: 34893630 DOI: 10.1038/s41541-021-00409-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Alghamdi S. The role of vaccines in combating antimicrobial resistance (AMR) bacteria. Saudi J Biol Sci 2021;28:7505-10. [PMID: 34867055 DOI: 10.1016/j.sjbs.2021.08.054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Duke JA, Paschall AV, Robinson LS, Knoot CJ, Vinogradov E, Scott NE, Feldman MF, Avci FY, Harding CM. Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine. ACS Infect Dis 2021;7:3111-23. [PMID: 34633812 DOI: 10.1021/acsinfecdis.1c00415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Adegbite A, McCarthy PC. Recent and Future Advances in the Chemoenzymatic Synthesis of Homogeneous Glycans for Bacterial Glycoconjugate Vaccine Development. Vaccines (Basel) 2021;9:1021. [PMID: 34579258 DOI: 10.3390/vaccines9091021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hwang SB, Chelliah R, Kang JE, Rubab M, Banan-MwineDaliri E, Elahi F, Oh DH. Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli. Front Cell Infect Microbiol 2021;11:614963. [PMID: 34268129 DOI: 10.3389/fcimb.2021.614963] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Knoot CJ, Robinson LS, Harding CM. A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS. Glycobiology 2021:cwab043. [PMID: 33997889 DOI: 10.1093/glycob/cwab043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Anderluh M, Berti F, Bzducha-Wróbel A, Chiodo F, Colombo C, Compostella F, Durlik K, Ferhati X, Holmdahl R, Jovanovic D, Kaca W, Lay L, Marinovic-Cincovic M, Marradi M, Ozil M, Polito L, Reina JJ, Reis CA, Sackstein R, Silipo A, Švajger U, Vaněk O, Yamamoto F, Richichi B, van Vliet SJ. Recent advances on smart glycoconjugate vaccines in infections and cancer. FEBS J 2021. [PMID: 33934527 DOI: 10.1111/febs.15909] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
16 Ramos-Martínez I, Vivanco-Rojas O, Juárez-Domínguez B, Hernández-Zimbrón L, Ochoa-de la Paz L, Quiroz-Mercado H, Ramírez-Hernández E, Gulias-Cañizo R, Zenteno E. Abnormal N-Glycosylation of Human Lens Epithelial Cells in Type-2 Diabetes May Contribute to Cataract Progression. Clin Ophthalmol 2021;15:1365-73. [PMID: 33833495 DOI: 10.2147/OPTH.S300242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang G, Glaser L, Scott NE, Fathy Mohamed Y, Ingram R, Laroucau K, Valvano MA. A glycoengineered antigen exploiting a conserved protein O-glycosylation pathway in the Burkholderia genus for detection of glanders infections. Virulence 2021;12:493-506. [PMID: 33509023 DOI: 10.1080/21505594.2021.1876440] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wiseman B, Nitharwal RG, Widmalm G, Högbom M. Structure of a full-length bacterial polysaccharide co-polymerase. Nat Commun 2021;12:369. [PMID: 33446644 DOI: 10.1038/s41467-020-20579-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
19 Wyszyńska A, Jabłuszewski R. PROTEIN GLYCOSYLATION IN BACTERIAL CELLS AND ITS POTENTIAL APPLICATIONS. Postępy Mikrobiologii - Advancements of Microbiology 2021;60:137-149. [DOI: 10.21307/pm-2019.60.2.11] [Reference Citation Analysis]
20 Melamed J, Brockhausen I. Biosynthesis of Bacterial Polysaccharides. Comprehensive Glycoscience 2021. [DOI: 10.1016/b978-0-12-819475-1.00097-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hershewe J, Kightlinger W, Jewett MC. Cell-free systems for accelerating glycoprotein expression and biomanufacturing. J Ind Microbiol Biotechnol 2020;47:977-91. [PMID: 33090335 DOI: 10.1007/s10295-020-02321-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
22 Rexer T, Laaf D, Gottschalk J, Frohnmeyer H, Rapp E, Elling L. Enzymatic Synthesis of Glycans and Glycoconjugates. Adv Biochem Eng Biotechnol 2021;175:231-80. [PMID: 33052414 DOI: 10.1007/10_2020_148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Sandomenico A, Sivaccumar JP, Ruvo M. Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments. Int J Mol Sci 2020;21:E6324. [PMID: 32878291 DOI: 10.3390/ijms21176324] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
24 Wang G, Glaser L, Scott NE, Mohamed YF, Ingram R, Laroucau K, Valvano MA. A glycoengineered antigen exploiting a conserved protein O-glycosylation pathway in the Burkholderia genus for diagnosis of glanders infections.. [DOI: 10.1101/2020.08.27.271338] [Reference Citation Analysis]
25 Ma B, Guan X, Li Y, Shang S, Li J, Tan Z. Protein Glycoengineering: An Approach for Improving Protein Properties. Front Chem 2020;8:622. [PMID: 32793559 DOI: 10.3389/fchem.2020.00622] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
26 Kightlinger W, Warfel KF, DeLisa MP, Jewett MC. Synthetic Glycobiology: Parts, Systems, and Applications. ACS Synth Biol 2020;9:1534-62. [PMID: 32526139 DOI: 10.1021/acssynbio.0c00210] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
27 Dow JM, Mauri M, Scott TA, Wren BW. Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production. Expert Review of Vaccines 2020;19:507-27. [DOI: 10.1080/14760584.2020.1775077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
28 Whitfield C, Williams DM, Kelly SD. Lipopolysaccharide O-antigens-bacterial glycans made to measure. J Biol Chem 2020;295:10593-609. [PMID: 32424042 DOI: 10.1074/jbc.REV120.009402] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 21.5] [Reference Citation Analysis]
29 Berti F, Micoli F. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs. Curr Opin Immunol 2020;65:42-9. [PMID: 32361591 DOI: 10.1016/j.coi.2020.03.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
30 Huang J, Pan C, Sun P, Feng E, Wu J, Zhu L, Wang H. Application of an O-Linked Glycosylation System in Yersinia enterocolitica Serotype O:9 to Generate a New Candidate Vaccine against Brucella abortus. Microorganisms 2020;8:E436. [PMID: 32244903 DOI: 10.3390/microorganisms8030436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
31 Budde I, Litschko C, Führing JI, Gerardy-Schahn R, Schubert M, Fiebig T. An enzyme-based protocol for cell-free synthesis of nature-identical capsular oligosaccharides from Actinobacillus pleuropneumoniae serotype 1. J Biol Chem 2020;295:5771-84. [PMID: 32152227 DOI: 10.1074/jbc.RA120.012961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Stachowski TR, Snell ME, Snell EH. Structural insights into conformational switching in latency-associated peptide between transforming growth factor β-1 bound and unbound states. IUCrJ 2020;7:238-52. [PMID: 32148852 DOI: 10.1107/S205225251901707X] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Feldman MF, Mayer Bridwell AE, Scott NE, Vinogradov E, McKee SR, Chavez SM, Twentyman J, Stallings CL, Rosen DA, Harding CM. A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae. Proc Natl Acad Sci U S A 2019;116:18655-63. [PMID: 31455739 DOI: 10.1073/pnas.1907833116] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 22.3] [Reference Citation Analysis]